Sr. Research Scientist / August, 2023 — December

Designed and conducted preclinical PK studies in rodent and non-rodent species. Performed PKTKBioequivalence analysis using Phoenix WinNonlin software and data interpretation with relevant parameters. Developed appropriate training plans SOPs and act as mentor to other staff. Engaged closely with technical and administrative staff oversaw reportees led initial-phase interviews and delivered training to new hires on PK study design and core operational processes. Summarized DMPK data from a variety of sources in clear and concise manner. Collaborated on multidisciplinary programs in oncology CNS and metabolic disorders supported progression from early drug discovery to clinical lead development. Served as primary DMPK representative for assigned projects; worked proactively in a matrix environment and supported DMPK programs from hit generation to clinical stages. Engaged with multiple clients in DD and FFS based projects. Reviewed and cross-checked PKTK and PKPD data within specified timelines. PK phase IB report preparation for IND submission. Prediction of different PK parameters for human using allometric scaling from multiple species. Designed in vitro assays and correlated outcomes with in vivo studies. Operated automated blood sampler BASi Culex for routine cannulated PK studies in rat. Integrated FIH dose prediction human PK data analysis for in-house projects.

Research Scientist / July, 2016 — July, 2023

Designed and conducted preclinical PK studies in rodent and non-rodent species. Performed PKTKBioequivalence analysis using Phoenix WinNonlin software and data interpretation with relevant parameters. Developed appropriate training plans SOPs and act as mentor to other staff. Engaged closely with technical and administrative staff oversaw reportees led initial-phase interviews and delivered training to new hires on PK study design and core operational processes. Summarized DMPK data from a variety of sources in clear and concise manner. Collaborated on multidisciplinary programs in oncology CNS and metabolic disorders supported progression from early drug discovery to clinical lead development. Served as primary DMPK representative for assigned projects; worked proactively in a matrix environment and supported DMPK programs from hit generation to clinical stages. Engaged with multiple clients in DD and FFS based projects. Reviewed and cross-checked PKTK and PKPD data within specified timelines. PK phase IB report preparation for IND submission. Prediction of different PK parameters for human using allometric scaling from multiple species. Designed in vitro assays and correlated outcomes with in vivo studies. Operated automated blood sampler BASi Culex for routine cannulated PK studies in rat. Integrated FIH dose prediction human PK data analysis for in-house projects.

Sr. Research Associate Scientist / January, 2009 — July, 2016

Designed and conducted preclinical PK studies in rodent and non-rodent species. Performed PKTKBioequivalence analysis using Phoenix WinNonlin software and data interpretation with relevant parameters. Developed appropriate training plans SOPs and act as mentor to other staff. Engaged closely with technical and administrative staff oversaw reportees led initial-phase interviews and delivered training to new hires on PK study design and core operational processes. Summarized DMPK data from a variety of sources in clear and concise manner. Collaborated on multidisciplinary programs in oncology CNS and metabolic disorders supported progression from early drug discovery to clinical lead development. Served as primary DMPK representative for assigned projects; worked proactively in a matrix environment and supported DMPK programs from hit generation to clinical stages. Engaged with multiple clients in DD and FFS based projects. Reviewed and cross-checked PKTK and PKPD data within specified timelines. PK phase IB report preparation for IND submission. Prediction of different PK parameters for human using allometric scaling from multiple species. Designed in vitro assays and correlated outcomes with in vivo studies. Operated automated blood sampler BASi Culex for routine cannulated PK studies in rat. Integrated FIH dose prediction human PK data analysis for in-house projects.

Research Associate / July, 2007 — January, 2009

Designed and conducted preclinical PK studies in rodent and non-rodent species. Performed PKTKBioequivalence analysis using Phoenix WinNonlin software and data interpretation with relevant parameters. Developed appropriate training plans SOPs and act as mentor to other staff. Engaged closely with technical and administrative staff oversaw reportees led initial-phase interviews and delivered training to new hires on PK study design and core operational processes. Summarized DMPK data from a variety of sources in clear and concise manner. Collaborated on multidisciplinary programs in oncology CNS and metabolic disorders supported progression from early drug discovery to clinical lead development. Served as primary DMPK representative for assigned projects; worked proactively in a matrix environment and supported DMPK programs from hit generation to clinical stages. Engaged with multiple clients in DD and FFS based projects. Reviewed and cross-checked PKTK and PKPD data within specified timelines. PK phase IB report preparation for IND submission. Prediction of different PK parameters for human using allometric scaling from multiple species. Designed in vitro assays and correlated outcomes with in vivo studies. Operated automated blood sampler BASi Culex for routine cannulated PK studies in rat. Integrated FIH dose prediction human PK data analysis for in-house projects.